In Vitro Anti-HIV-1 Activities of Kaempferol and Kaempferol-7-O-glucoside Isolated from Securigera Securidaca

Overview

Journal Res Pharm Sci

Specialty Chemistry

Date 2015 Sep 5

PMID 26339261

Citations 28

Authors

M Behbahani

S Sayedipour

A Pourazar

M Shanehsazzadeh

Affiliations

Soon will be listed here.

Abstract

Previously, we reported that the kaempferol and kaempferol-7-O-glucoside isolated from Securigera securidaca showed potent anti-HSV activity. In the present study the anti-HIV-1 activities of kaempferol and kaempferol-7-O-glucoside are investigated at different concentrations (100, 50, 25 and 10 μg/ml) using HIV-1 p24 Antigen kit. Real-time Polymerase chain reaction (RT-PCR) assay was also used for quantification of full range of virus load observed in treated and untreated cells. According to the results of RT- PCR, tested compounds at a concentration of 100 μg/ml exerted potent inhibitory effect. Time of drug addition experiments demonstrated that these compounds exerted their inhibitory effects on the early stage of HIV infection. The results also showed potent anti-HIV-1 reverse transcriptase activity. Antiviral activity of kaempferol-7-O-glucoside was more pronounced than that of kaempferol. These findings demonstrate that kaempferol-7-O-glucoside could be considered as a new potential drug candidate for the treatment of HIV infection which requires further assessments.

Citing Articles

Bibliometric and visual analysis of global publications on kaempferol.

Tang R, Lin L, Liu Y, Li H Front Nutr. 2024; 11:1442574.

PMID: 39221164 PMC: 11362042. DOI: 10.3389/fnut.2024.1442574.

Fighting nature with nature: antiviral compounds that target retroviruses.

Siew Z, Asudas E, Khoo C, Cho G, Voon K, Fang C Arch Microbiol. 2024; 206(3):130.

PMID: 38416180 DOI: 10.1007/s00203-024-03846-3.

Kaempferol: A Review of Current Evidence of Its Antiviral Potential.

Periferakis A, Periferakis A, Troumpata L, Periferakis K, Scheau A, Savulescu-Fiedler I Int J Mol Sci. 2023; 24(22).

PMID: 38003488 PMC: 10671393. DOI: 10.3390/ijms242216299.

Antiviral Activity of Natural Herbs and their Isolated BioactiveCompounds: A Review.

Singh S, Murti Y, Semwal B Comb Chem High Throughput Screen. 2023; 27(14):2013-2042.

PMID: 37957899 DOI: 10.2174/0113862073267048231027070537.

Herb Robert's Gift against Human Diseases: Anticancer and Antimicrobial Activity of L.

Swiatek L, Wasilewska I, Boguszewska A, Grzegorczyk A, Rezmer J, Rajtar B Pharmaceutics. 2023; 15(5).

PMID: 37242803 PMC: 10223082. DOI: 10.3390/pharmaceutics15051561.

References

Wang R, Gu Q, Yang L, Chen J, Li S, Zheng Y . Anti-HIV-1 activities of extracts from the medicinal plant Rhus chinensis. J Ethnopharmacol. 2005; 105(1-2):269-73. DOI: 10.1016/j.jep.2005.11.008. View

LeGoff J, Bouhlal H, Gresenguet G, Weiss H, Khonde N, Hocini H . Real-time PCR quantification of genital shedding of herpes simplex virus (HSV) and human immunodeficiency virus (HIV) in women coinfected with HSV and HIV. J Clin Microbiol. 2006; 44(2):423-32. PMC: 1392666. DOI: 10.1128/JCM.44.2.423-432.2006. View

Garjani A, Fathiazad F, Zakheri A, Allaf Akbari N, Azarmie Y, Fakhrjoo A . The effect of total extract of Securigera securidaca L. seeds on serum lipid profiles, antioxidant status, and vascular function in hypercholesterolemic rats. J Ethnopharmacol. 2009; 126(3):525-32. DOI: 10.1016/j.jep.2009.09.003. View

Harnett S, Oosthuizen V, van de Venter M . Anti-HIV activities of organic and aqueous extracts of Sutherlandia frutescens and Lobostemon trigonus. J Ethnopharmacol. 2004; 96(1-2):113-9. DOI: 10.1016/j.jep.2004.08.038. View

Vermani K, Garg S . Herbal medicines for sexually transmitted diseases and AIDS. J Ethnopharmacol. 2002; 80(1):49-66. DOI: 10.1016/s0378-8741(02)00009-0. View

Rates S . Plants as source of drugs. Toxicon. 2000; 39(5):603-13. DOI: 10.1016/s0041-0101(00)00154-9. View

Rouet F, Ekouevi D, Chaix M, Burgard M, Inwoley A, Tony T . Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting. J Clin Microbiol. 2005; 43(6):2709-17. PMC: 1151915. DOI: 10.1128/JCM.43.6.2709-2717.2005. View

Min B, Tomiyama M, Ma C, Nakamura N, Hattori M . Kaempferol acetylrhamnosides from the rhizome of Dryopteris crassirhizoma and their inhibitory effects on three different activities of human immunodeficiency virus-1 reverse transcriptase. Chem Pharm Bull (Tokyo). 2001; 49(5):546-50. DOI: 10.1248/cpb.49.546. View

Kim T, Ku S, Lee I, Bae J . Anti-inflammatory effects of kaempferol-3-O-sophoroside in human endothelial cells. Inflamm Res. 2011; 61(3):217-24. DOI: 10.1007/s00011-011-0403-9. View

10.

Yarmolinsky L, Huleihel M, Zaccai M, Ben-Shabat S . Potent antiviral flavone glycosides from Ficus benjamina leaves. Fitoterapia. 2011; 83(2):362-7. DOI: 10.1016/j.fitote.2011.11.014. View

11.

De Clercq E . Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV. Int J Antimicrob Agents. 2008; 33(4):307-20. DOI: 10.1016/j.ijantimicag.2008.10.010. View

12.

Mukhtar M, Arshad M, Ahmad M, Pomerantz R, Wigdahl B, Parveen Z . Antiviral potentials of medicinal plants. Virus Res. 2007; 131(2):111-20. PMC: 7114233. DOI: 10.1016/j.virusres.2007.09.008. View

13.

Mahmood N, Piacente S, Pizza C, Burke A, Khan A, Hay A . The anti-HIV activity and mechanisms of action of pure compounds isolated from Rosa damascena. Biochem Biophys Res Commun. 1996; 229(1):73-9. DOI: 10.1006/bbrc.1996.1759. View

14.

Chu S, Hsieh Y, Lin J . Inhibitory effects of flavonoids on Moloney murine leukemia virus reverse transcriptase activity. J Nat Prod. 1992; 55(2):179-83. DOI: 10.1021/np50080a005. View